A synthetic peptide vector system for op
โ
Louise Collins; John W. Fabre
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 194 KB
## Background: Efficient and non-toxic gene delivery, preferably with non-viral dna vectors readily transferable to clinical practice, is generally regarded as a major limitation for gene therapy. ## Methods: A 31 amino acid, integrin-targeted bifunctional synthetic peptide (polylysine-molossin),